CanOmix develops science-based technologies designed to bring increased accuracy, efficiency, and safety to medical cannabis cultivation. CanOmix has developed genetic markers to identify the medical potential of cannabis plants. These markers are integrated into the company's cannabis-breeding technology, leading to savings in time, money, space, and manpower. The company's R&D center, located in Israel, collaborates with academic and commercial partners worldwide.